Health care stocks were flat to edging higher pre-bell Monday as the iShares Biotechnology ETF (IBB) was inactive and the Health Care Select Sector SPDR Fund (XLV) was up 0.2% recently.
Pliant Therapeutics (PLRX) shares declined by nearly 61% after the company said it has suspended enrollment and treatment in a phase 2b trial of bexotegrast for idiopathic pulmonary fibrosis following a recommendation from the trial's data safety monitoring board.
Roivant Sciences (ROIV) shares were up nearly 6% even after the company reported lower fiscal Q3 earnings and revenue.
DocGo (DCGO) shares rose past 3% after the company said it has acquired PTI Health to add mobile phlebotomy lab services to its portfolio.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.